We are live on ! Find out more
GC

Gratry & Company Portfolio holdings

AUM $72.2M
1-Year Est. Return 19.87%
This Fund
S&P 500
This Quarter Est. Return
-3.77%
1 Year Est. Return
+19.87%
3 Year Est. Return
+44.17%
5 Year Est. Return
+89.51%
10 Year Est. Return
–
AUM
$305M
AUM Growth
+$114M
Cap. Flow
+$94.3M
Cap. Flow %
30.9%
Top 10 Hldgs %
32.27%
Holding
83
New
22
Increased
37
Reduced
8
Closed
14

Top Buys

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$11M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$9.37M
3
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
+$8.42M
4
AZ
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
+$8.16M
5
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
+$7.27M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.66M
2
ICLR icon
Icon
ICLR
+$6.45M
3
SLB icon
SLB Ltd
SLB
+$5.93M
4
PUK icon
Prudential
PUK
+$5.36M
5
NVO
Novo Nordisk
NVO
+$4.86M

Sector Composition

Rank Sector Weight
1 Financials 18.58%
2 Healthcare 18.22%
3 Industrials 11.69%
4 Consumer Discretionary 7.34%
5 Technology 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JAZZ icon
1
Jazz Pharmaceuticals
JAZZ
$15.7B
$12.6M 4.12%
99,273
+56,430
+132% +$9.37M
CBI
2
DELISTED
Chicago Bridge & Iron Nv
CBI
$11.7M 3.83%
140,713
+35,347
+34% +$1.74M
NXPI icon
3
NXP Semiconductors
NXPI
$70.4B
$10.1M 3.3%
219,330
+64,044
+41% +$4.54M
BAY
4
DELISTED
BAYER AG SPONS ADR
BAY
$9.92M 3.25%
69,847
+19,390
+38% +$2.75M
ETN icon
5
Eaton
ETN
$158B
$9.51M 3.11%
124,881
+81,861
+190% +$5.4M
CB icon
6
Chubb
CB
$133B
$8.92M 2.92%
86,141
+22,064
+34% +$2.44M
DT
7
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$8.66M 2.84%
501,820
+194,729
+63% +$3.36M
ING icon
8
ING
ING
$95.2B
$8.63M 2.83%
615,840
+175,202
+40% +$2.44M
TM icon
9
Toyota
TM
$213B
$8.59M 2.81%
70,433
+24,142
+52% +$2.9M
IX icon
10
ORIX
IX
$44.3B
$8.45M 2.77%
+474,125
New +$6.2M
SI
11
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$8.42M 2.76%
+60,799
New +$8.42M
NVS icon
12
Novartis
NVS
$291B
$8.34M 2.73%
115,734
+35,459
+44% +$2.94M
NVO
13
Novo Nordisk
NVO
$213B
$8.25M 2.7%
89,318
-217,420
-71% -$4.86M
AZ
14
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
$8.16M 2.67%
+450,095
New +$8.16M
LYB icon
15
LyondellBasell Industries
LYB
$20.1B
$8.16M 2.67%
101,635
+25,968
+34% +$2.25M
SMFG icon
16
Sumitomo Mitsui Financial
SMFG
$166B
$8.15M 2.67%
+777,395
New +$5.9M
APTV icon
17
Aptiv
APTV
$12.3B
$8.02M 2.63%
133,295
+43,330
+48% +$2.99M
WX
18
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$7.9M 2.59%
+205,800
New +$7.27M
COV
19
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$7.77M 2.55%
+114,152
New +$11M
DEO icon
20
Diageo
DEO
$46.9B
$7.04M 2.31%
53,140
+16,056
+43% +$1.87M
ESV
21
DELISTED
Ensco Rowan plc
ESV
$6.83M 2.24%
+29,846
New +$4.28M
SDRL
22
DELISTED
Seadrill Limited Common Stock
SDRL
$6.78M 2.22%
616
+173
+39% +$869K
BRG
23
DELISTED
BG GROUP PLC ADS(RP 5 ORD SHS)
BRG
$6.63M 2.17%
+305,680
New +$6.63M
CEO
24
DELISTED
CNOOC Limited
CEO
$6.05M 1.98%
+32,236
New +$4.83M
NGG icon
25
National Grid
NGG
$83.5B
$5.89M 1.93%
93,480
+20,393
+28% +$1.42M
1
2 3

Similar funds

T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
DCM
Delpha Capital Management New York $72.9M AUM
XS
XML Securities Bethesda, Maryland $80.6M AUM
BSCP
Bay Street Capital Partners New York $81.9M AUM
SCM
Stonerise Capital Management San Francisco, California $62.6M AUM 1.3% 1-Year Est. Return
FMA
FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return
MSTVIM
Messner & Smith Theme Value Investment Management San Diego, California $60.3M AUM 16.8% 1-Year Est. Return
LA
Lucus Advisors New York $57.7M AUM 0.6% 1-Year Est. Return

Gratry & Company's Q4 2014 Portfolio in Review

As of Q4 2014, Gratry & Company held 83 positions worth $305M, up 60% from $191M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Gratry & Company deployed $94.3M of net new capital in Q4 2014, opening 22 new positions and adding to 37 existing holdings. Its largest new stake was COVIDIEN PLC COM SHS NEW (IRELAND): 114,152 shares worth $7.77M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 10% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Novo Nordisk, an estimated $4.86M trimmed.

  • Gratry & Company's largest Q4 2014 buy was COVIDIEN PLC COM SHS NEW (IRELAND): 114,152 shares worth $7.77M.
  • Gratry & Company added most to Jazz Pharmaceuticals in Q4 2014, an estimated $9.37M increase.
  • Gratry & Company's biggest Q4 2014 reduction was Novo Nordisk, cutting an estimated $4.86M.
  • Gratry & Company fully exited Allergan plc in Q4 2014, selling an estimated $6.66M.
  • Gratry & Company's ten largest holdings make up 32% of its $305M portfolio in Q4 2014.
  • Gratry & Company opened 22 new positions and closed 14 in Q4 2014.
  • Gratry & Company's portfolio value rose 60% quarter-over-quarter to $305M.

Based on Gratry & Company's 13F filing for Q4 2014, filed 18 Feb 2015.